Skip to main content
. 2021 Jul 19;12:709974. doi: 10.3389/fmicb.2021.709974

TABLE 1.

kinact/Ki and koff of durlobactam and kinact/Ki for avibactam with β-lactamasesa.

Class β -Lactamase Durlobactam Durlobactam Avibactam
kinact/Ki (M1 s1) koff (s1) kinact/Ki (M1 s1)
A CTX-M-15 7 (±2) × 106 2.2 (±0.5) × 10–4 8 × 105
A SHV-5 6.4 (±0.5) × 106 5.5 (±0.3) × 10–4 1 × 105
A TEM-1 1.4 (±0.6) × 107 1.4 (±0.2) × 10–3 4 × 105
A KPC-2 9.3 (±0.6) × 105 1.0 (±0.1) × 10–3 6 × 103
A KPC-3 8 (±1) × 105 2.7 (±0.7) × 10–4 7.1 (± 0.7) × 103
C Pseudomonas aeruginosa AmpC 9 (±5) × 105 4 (±1) × 10–3 3 × 103
C Enterobacter cloacae P99 2.3 (±0.4) × 106 3.4 (±0.1) × 10–4 8 × 103
C Acinetobacter baumannii ADC-7 1.0 (±0.1) × 106 8 (±1) × 10–4 NT
D OXA-10 9 (±2) × 103 3.4 (±0.1) × 10–6 70
D OXA-23 5.1 (±0.2) × 103 1.10 (±0.04) × 10–5 100
D OXA-24 9 (±2) × 103 1.7 (±0.1) × 10–5 80
D OXA-48 8 (±2) × 105 2.5 (±0.3) × 10–5 5 × 103
D OXA-58 2.5 (±0.3) × 105 1.6 (±0.3) × 10–4 120 ± 40
D OXA-66 6 (±0.7) × 102 NT NT

aValues shown are averages ± standard deviations, or single measurements. The kinact/Ki parameter is described in Tonge (2019). Measurements are from Durand-Reville et al. (2017), Shapiro and Gao (2021); Shapiro et al. (2021),Barnes et al. (2019) and Vázquez-Ucha et al. (2017). NT, not tested.